TY - JOUR AU - Fallowfield, L. AU - Atkins, L. AU - Catt, S. AU - Cox, A. AU - Coxon, C. AU - Langridge, C. AU - Morris, R. AU - Price, M. PY - 2006 DA - 2006// TI - Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdj044 DO - 10.1093/annonc/mdj044 ID - Fallowfield2006 ER - TY - JOUR AU - Liu, G. AU - Franssen, E. AU - Fitch, M. I. AU - Warner, E. PY - 1997 DA - 1997// TI - Patient preferences for oral versus intravenous palliative chemotherapy JO - J Clin Oncol VL - 15 ID - Liu1997 ER - TY - JOUR AU - Kruse, G. B. AU - Amonkar, M. M. AU - Smith, G. AU - Skonieczny, D. C. AU - Stavrakas, S. PY - 2008 DA - 2008// TI - Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a U.S. population JO - J Manag Care Pharm VL - 14 ID - Kruse2008 ER - TY - JOUR AU - Twelves, C. J. PY - 2006 DA - 2006// TI - Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness JO - Clin Colorectal Cancer VL - 6 UR - https://doi.org/10.3816/CCC.2006.n.046 DO - 10.3816/CCC.2006.n.046 ID - Twelves2006 ER - TY - JOUR AU - Ward, S. E. AU - Kaltenthaler, E. AU - Cowan, J. AU - Marples, M. AU - Orr, B. AU - Seymour, M. T. PY - 2006 DA - 2006// TI - The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer JO - Br J Cancer VL - 10/28 ID - Ward2006 ER - TY - BOOK AU - Sabaté, E. PY - 2003 DA - 2003// TI - Adherence to long-term therapies Evidence for action PB - World Health Organization CY - Geneva ID - Sabaté2003 ER - TY - JOUR AU - Tebbi, C. K. PY - 1993 DA - 1993// TI - Treatment compliance in childhood and adolescence JO - Cancer VL - 71 UR - https://doi.org/3.0.CO;2-P DO - 3.0.CO;2-P ID - Tebbi1993 ER - TY - JOUR AU - Cramer, J. A. AU - Roy, A. AU - Burrell, A. AU - Fairchild, C. J. AU - Fuldeore, M. J. AU - Ollendorf, D. A. AU - Wong, P. K. PY - 2008 DA - 2008// TI - Medication compliance and persistence: terminology and definitions JO - Value Health VL - 11 UR - https://doi.org/10.1111/j.1524-4733.2007.00213.x DO - 10.1111/j.1524-4733.2007.00213.x ID - Cramer2008 ER - TY - JOUR AU - Ruddy, K. AU - Mayer, E. AU - Partridge, A. PY - 2009 DA - 2009// TI - Patient adherence and persistence with oral anticancer treatment JO - CA Cancer J Clin VL - 59 UR - https://doi.org/10.3322/caac.20004 DO - 10.3322/caac.20004 ID - Ruddy2009 ER - TY - JOUR AU - Partridge, A. H. AU - Avorn, J. AU - Wang, P. S. AU - Winer, E. P. PY - 2002 DA - 2002// TI - Adherence to therapy with oral antineoplastic agents JO - J Natl Cancer Inst VL - 94 UR - https://doi.org/10.1093/jnci/94.9.652 DO - 10.1093/jnci/94.9.652 ID - Partridge2002 ER - TY - JOUR AU - Yeaw, J. AU - Benner, J. S. AU - Walt, J. G. AU - Sian, S. AU - Smith, D. B. PY - 2009 DA - 2009// TI - Comparing adherence and persistence across 6 chronic medication classes JO - J Manag Care Pharm VL - 15 ID - Yeaw2009 ER - TY - JOUR AU - Klein, C. E. AU - Kastrissios, H. AU - Miller, A. A. AU - Hollis, D. AU - Yu, D. AU - Rosner, G. L. AU - Grinblatt, D. L. AU - Larson, R. A. AU - Ratain, M. J. PY - 2006 DA - 2006// TI - Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study JO - Cancer Chemother Pharmacol VL - 57 UR - https://doi.org/10.1007/s00280-005-0023-6 DO - 10.1007/s00280-005-0023-6 ID - Klein2006 ER - TY - JOUR AU - Waterhouse, D. M. AU - Calzone, K. A. AU - Mele, C. AU - Brenner, D. E. PY - 1993 DA - 1993// TI - Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring JO - J Clin Oncol VL - 11 ID - Waterhouse1993 ER - TY - JOUR AU - Nilsson, J. L. G. AU - Andersson, K. AU - Bergkvist, A. AU - Bjorkman, I. AU - Brismar, A. AU - Moen, J. PY - 2006 DA - 2006// TI - Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients JO - Eur J Cancer Care (Engl) VL - 15 UR - https://doi.org/10.1111/j.1365-2354.2006.00645.x DO - 10.1111/j.1365-2354.2006.00645.x ID - Nilsson2006 ER - TY - JOUR AU - Noens, L. AU - van Lierde, M. A. AU - De Bock, R. AU - Verhoef, G. AU - Zachee, P. AU - Berneman, Z. AU - Martiat, P. AU - Mineur, P. AU - van Eygen, K. AU - MacDonald, K. AU - De Geest, S. AU - Altrecht, T. AU - Abraham, I. PY - 2009 DA - 2009// TI - Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-12-196543 DO - 10.1182/blood-2008-12-196543 ID - Noens2009 ER - TY - JOUR AU - Partridge, A. H. AU - Wang, P. S. AU - Winer, E. P. AU - Avorn, J. PY - 2003 DA - 2003// TI - Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.07.071 DO - 10.1200/JCO.2003.07.071 ID - Partridge2003 ER - TY - JOUR AU - Ruddy, K. J. AU - Partridge, A. H. PY - 2009 DA - 2009// TI - Adherence with adjuvant hormonal therapy for breast cancer JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdp039 DO - 10.1093/annonc/mdp039 ID - Ruddy2009 ER - TY - JOUR AU - Marin, D. AU - Bazeos, A. AU - Mahon, F. AU - Eliasson, L. AU - Milojkovic, D. AU - Bua, M. AU - Apperley, J. F. AU - Szydlo, R. AU - Desai, R. AU - Kazlowski, K. AU - Paliompeis, C. AU - Latham, V. AU - Foroni, L. AU - Molimard, M. AU - Reid, A. AU - Rezvani, K. AU - de Lavallade, H. AU - Guallar, C. AU - Goldman, J. AU - Khorashad, J. S. PY - 2010 DA - 2010// TI - Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.3087 DO - 10.1200/JCO.2009.26.3087 ID - Marin2010 ER - TY - JOUR AU - Wu, E. Q. AU - Guerin, A. AU - Yu, A. P. AU - Bollu, V. K. AU - Guo, A. AU - Griffin, J. D. PY - 2010 DA - 2010// TI - Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007995.2010.533648 DO - 10.1185/03007995.2010.533648 ID - Wu2010 ER - TY - JOUR AU - McAndrew, L. M. AU - Musumeci-Szabo, T. J. AU - Mora, P. A. AU - Vileikyte, L. AU - Burns, E. AU - Halm, E. A. AU - Leventhal, E. A. AU - Leventhal, H. PY - 2008 DA - 2008// TI - Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process JO - Br J Health Psychol VL - 13 UR - https://doi.org/10.1348/135910708X295604 DO - 10.1348/135910708X295604 ID - McAndrew2008 ER - TY - JOUR AU - Broadbent, E. AU - Petrie, K. J. AU - Main, J. AU - Weinman, J. PY - 2006 DA - 2006// TI - The brief illness perception questionnaire JO - J Psychosom Res VL - 60 UR - https://doi.org/10.1016/j.jpsychores.2005.10.020 DO - 10.1016/j.jpsychores.2005.10.020 ID - Broadbent2006 ER - TY - JOUR AU - Horne, R. AU - Weinman, J. AU - Hankins, M. PY - 1999 DA - 1999// TI - The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication JO - Psychology and Health VL - 14 UR - https://doi.org/10.1080/08870449908407311 DO - 10.1080/08870449908407311 ID - Horne1999 ER - TY - JOUR AU - Horne, R. AU - Cooper, V. AU - Gellaitry, G. AU - Date, H. L. AU - Fisher, M. PY - 2007 DA - 2007// TI - Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework JO - J Acquir Immune Defic Syndr VL - 1/45 ID - Horne2007 ER - TY - JOUR AU - Jonsdottir, H. AU - Friis, S. AU - Horne, R. AU - Pettersen, K. I. AU - Reikvam, A. AU - Andreassen, O. A. PY - 2009 DA - 2009// TI - Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders JO - Acta Psychiatr Scand VL - 119 UR - https://doi.org/10.1111/j.1600-0447.2008.01279.x DO - 10.1111/j.1600-0447.2008.01279.x ID - Jonsdottir2009 ER - TY - JOUR AU - Mardby, A. C. AU - Akerlind, I. AU - Jorgensen, T. PY - 2007 DA - 2007// TI - Beliefs about medicines and self-reported adherence among pharmacy clients JO - Patient Educ Couns VL - 69 UR - https://doi.org/10.1016/j.pec.2007.08.011 DO - 10.1016/j.pec.2007.08.011 ID - Mardby2007 ER - TY - JOUR AU - Menckeberg, T. T. AU - Bouvy, M. L. AU - Bracke, M. AU - Kaptein, A. A. AU - Leufkens, H. G. AU - Raaijmakers, J. A. M. PY - 2008 DA - 2008// TI - Beliefs about medicines predict refill adherence to inhaled corticosteroids JO - J Psychosom Res VL - 64 UR - https://doi.org/10.1016/j.jpsychores.2007.07.016 DO - 10.1016/j.jpsychores.2007.07.016 ID - Menckeberg2008 ER - TY - JOUR AU - Schuz, B. AU - Marx, C. AU - Wurm, S. AU - Warner, L. M. AU - Ziegelmann, J. P. AU - Schwarzer, R. PY - 2011 DA - 2011// TI - Medication beliefs predict medication adherence in older adults with multiple illnesses JO - J Psychosom Res VL - 70 UR - https://doi.org/10.1016/j.jpsychores.2010.07.014 DO - 10.1016/j.jpsychores.2010.07.014 ID - Schuz2011 ER - TY - JOUR AU - Eliasson, L. AU - Clifford, S. AU - Barber, N. AU - Marin, D. PY - 2011 DA - 2011// TI - Exploring chronic myeloid leukemia patients' reasons for not adhering to the oral anticancer drug imatinib as prescribed JO - Leuk Res VL - 35 UR - https://doi.org/10.1016/j.leukres.2010.10.017 DO - 10.1016/j.leukres.2010.10.017 ID - Eliasson2011 ER - TY - JOUR AU - Basch, E. AU - Jia, X. AU - Heller, G. AU - Barz, A. AU - Sit, L. AU - Fruscione, M. PY - 2009 DA - 2009// TI - Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp386 DO - 10.1093/jnci/djp386 ID - Basch2009 ER - TY - JOUR AU - Basch, E. PY - 2010 DA - 2010// TI - The missing voice of patients in drug-safety reporting JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMp0911494 DO - 10.1056/NEJMp0911494 ID - Basch2010 ER - TY - BOOK PY - 2010 DA - 2010// TI - Tarceva: European Public Assessment Report Product Information. Annex I: Summary of product characteristics ID - ref31 ER - TY - JOUR AU - Hidalgo, M. AU - Siu, L. L. AU - Nemunaitis, J. AU - Rizzo, J. AU - Hammond, L. A. AU - Takimoto, C. PY - 2001 DA - 2001// TI - Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies JO - J Clin Oncol VL - 19 ID - Hidalgo2001 ER - TY - JOUR AU - Rudin, C. M. AU - Liu, W. AU - Desai, A. AU - Karrison, T. AU - Jiang, X. AU - Janisch, L. PY - 2008 DA - 2008// TI - Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.13.1128 DO - 10.1200/JCO.2007.13.1128 ID - Rudin2008 ER - TY - JOUR AU - Perez-Soler, R. AU - Chachoua, A. AU - Hammond, L. A. AU - Rowinsky, E. K. AU - Huberman, M. AU - Karp, D. PY - 2004 DA - 2004// TI - Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.11.057 DO - 10.1200/JCO.2004.11.057 ID - Perez-Soler2004 ER - TY - JOUR AU - Wacker, B. AU - Nagrani, T. AU - Weinberg, J. AU - Witt, K. AU - Clark, G. AU - Cagnoni, P. J. PY - 2007 DA - 2007// TI - Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2610 DO - 10.1158/1078-0432.CCR-06-2610 ID - Wacker2007 ER - TY - JOUR AU - Lu, J. F. AU - Eppler, S. M. AU - Wolf, J. AU - Hamilton, M. AU - Rakhit, A. AU - Bruno, R. PY - 2006 DA - 2006// TI - Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer JO - Clin Pharmacol Ther VL - 80 UR - https://doi.org/10.1016/j.clpt.2006.04.007 DO - 10.1016/j.clpt.2006.04.007 ID - Lu2006 ER - TY - JOUR AU - Li, J. AU - Cusatis, G. AU - Brahmer, J. AU - Sparreboom, A. AU - Robey, R. W. AU - Bates, S. E. PY - 2007 DA - 2007// TI - Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients JO - Cancer Biol Ther VL - 6 UR - https://doi.org/10.4161/cbt.6.3.3763 DO - 10.4161/cbt.6.3.3763 ID - Li2007 ER - TY - JOUR AU - Hamilton, M. AU - Wolf, J. L. AU - Rusk, J. AU - Beard, S. E. AU - Clark, G. M. AU - Witt, K. PY - 2006 DA - 2006// TI - Effects of smoking on the pharmacokinetics of erlotinib JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-2235 DO - 10.1158/1078-0432.CCR-05-2235 ID - Hamilton2006 ER - TY - JOUR AU - Ling, J. AU - Fettner, S. AU - Lum, B. L. AU - Riek, M. AU - Rakhit, A. PY - 2008 DA - 2008// TI - Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals JO - Anticancer Drugs VL - 19 UR - https://doi.org/10.1097/CAD.0b013e3282f2d8e4 DO - 10.1097/CAD.0b013e3282f2d8e4 ID - Ling2008 ER - TY - JOUR AU - Butler, J. A. AU - Peveler, R. C. AU - Roderick, P. AU - Horne, R. AU - Mason, J. C. PY - 2004 DA - 2004// TI - Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring JO - Transplantation VL - 77 UR - https://doi.org/10.1097/01.TP.0000110412.20050.36 DO - 10.1097/01.TP.0000110412.20050.36 ID - Butler2004 ER - TY - JOUR AU - Horne, R. AU - Hankins, M. AU - Jenkins, R. PY - 2001 DA - 2001// TI - The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research JO - Qual Health Care VL - 10 UR - https://doi.org/10.1136/qhc.0100135 DO - 10.1136/qhc.0100135 ID - Horne2001 ER - TY - JOUR AU - Aaronson, N. K. AU - Muller, M. AU - Essink-Bot, M. L. AU - Fekkes, M. AU - Sanderman, R. AU - te Velde, A. AU - Verrips, E. PY - 1998 DA - 1998// TI - Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations JO - J Clin Epidemiol VL - 51 UR - https://doi.org/10.1016/S0895-4356(98)00097-3 DO - 10.1016/S0895-4356(98)00097-3 ID - Aaronson1998 ER - TY - JOUR AU - Hurst, N. P. AU - Ruta, D. A. AU - Kind, P. PY - 1998 DA - 1998// TI - Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis JO - Br J Rheumatol VL - 37 UR - https://doi.org/10.1093/rheumatology/37.8.862 DO - 10.1093/rheumatology/37.8.862 ID - Hurst1998 ER - TY - JOUR AU - Olivieri, N. F. AU - Matsui, D. AU - Hermann, C. AU - Koren, G. PY - 1991 DA - 1991// TI - Compliance assessed by the Medication Event Monitoring System JO - Arch Dis Child VL - 66 UR - https://doi.org/10.1136/adc.66.12.1399 DO - 10.1136/adc.66.12.1399 ID - Olivieri1991 ER - TY - JOUR AU - Denhaerynck, K. AU - Schäfer-Keller, P. AU - Young, J. AU - Steiger, J. AU - Bock, A. AU - De Geest, S. PY - 2008 DA - 2008// TI - Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients JO - BMC Medical Research Methodology VL - 8 UR - https://doi.org/10.1186/1471-2288-8-5 DO - 10.1186/1471-2288-8-5 ID - Denhaerynck2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/11/284/prepub UR - http://www.biomedcentral.com/1471-2407/11/284/prepub ID - ref46 ER -